Literature DB >> 3396490

Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study.

M Michéa-Hamzehpour1, R Auckenthaler, J Kunz, J C Pechère.   

Abstract

The effect of cefotaxime and ceftriaxone on faecal flora was investigated in women undergoing routine vaginal or abdominal hysterectomy. Three groups of 9 patients received, in a double-blind fashion and just before surgery, cefotaxime 2g intravenously, ceftriaxone 2g intravenously or no antibiotic (controls). Stools were collected before prophylaxis (sample 1) and after surgery (samples 2 and 3). The only alteration after cefotaxime was a decrease of non-fastidious aerobic Gram-negative flora in sample 2. The same effect was more pronounced after ceftriaxone (p less than 0.01) which, in addition, increased yeast colonies (p less than 0.05) in sample 2. In sample 3, more resistant (MIC greater than 32 mg/L) aerobic and anaerobic bacteria were found after ceftriaxone (log10 median 7.5 and 9.0, respectively) than after cefotaxime (4.2 and 6.0) or in controls (4.4 and 6.6) [p less than 0.01 in each case]. Group D streptococci and Gram-positive cocci remained unchanged in the 3 groups. Clostridium difficile cytotoxin assays were negative. The effects on faecal flora were more pronounced after ceftriaxone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396490     DOI: 10.2165/00003495-198800352-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

Review 2.  Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Cefotaxime in children: efficacy, tolerance and effect on the intestinal bacterial flora.

Authors:  N Lambert-Zechovsky; C Aufrant; E Bingen; C Blum; M C Proux; H Mathieu
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

Review 4.  Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

Authors:  C E Nord; L Kager; A Heimdahl
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

5.  Ceftriaxone: renal and biliary excretion and effect on the colon microflora.

Authors:  A Arvidsson; G Alván; B Angelin; O Borgå; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

6.  Effect of broad-spectrum cephalosporins on the microbial flora of recipients.

Authors:  G P Bodey; V Fainstein; I Garcia; B Rosenbaum; Y Wong
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

7.  Metabolism of cefotaxime: a review.

Authors:  H B Lassman; J D Coombes
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

8.  Influence of third-generation cephalosporins on aerobic intestinal flora.

Authors:  J P Guggenbichler; J Kofler
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

9.  Impact of cefoperazone therapy on fecal flora.

Authors:  M E Mulligan; D M Citron; B T McNamara; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Effect of moxalactam on human fecal microflora.

Authors:  Y Benno; N Shiragami; K Uchida; T Yoshida; T Mitsuoka
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

View more
  10 in total

1.  Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.

Authors:  Charles Burdet; Nathalie Grall; Morgane Linard; Antoine Bridier-Nahmias; Michèle Benhayoun; Khadija Bourabha; Mélanie Magnan; Olivier Clermont; Camille d'Humières; Olivier Tenaillon; Erick Denamur; Laurent Massias; Sarah Tubiana; Loubna Alavoine; Antoine Andremont; France Mentré; Xavier Duval
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract.

Authors:  G W Welling; G J Meijer-Severs; G Helmus; E van Santen; R H Tonk; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

3.  Randomized, double-blind comparison of the efficacies, costs, and vaginal flora alterations with single-dose ceftriaxone and multidose cefazolin prophylaxis in vaginal hysterectomy.

Authors:  H G Stiver; B O Binns; R C Brunham; N Cheng; D M Dean; A M Goldring; J B Walker; E Tan; J McLeod
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.

Authors:  G Bodey; D Abi-Said; K Rolston; I Raad; E Whimbey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

Review 5.  Bacterial resistance: new threats, new challenges.

Authors:  J C Pechère
Journal:  Support Care Cancer       Date:  1993-05       Impact factor: 3.603

Review 6.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

7.  Modeling the bacterial dynamics in the gut microbiota following an antibiotic-induced perturbation.

Authors:  Jinju Guk; Antoine Bridier-Nahmias; Mélanie Magnan; Nathalie Grall; Xavier Duval; Olivier Clermont; Etienne Ruppé; Camille d'Humières; Olivier Tenaillon; Erick Denamur; France Mentré; Jérémie Guedj; Charles Burdet
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-18

8.  Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.

Authors:  G Samonis; A Gikas; E J Anaissie; G Vrenzos; S Maraki; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.

Authors:  M Michéa-Hamzehpour; A Kahr; J C Pechère
Journal:  Infection       Date:  1994       Impact factor: 3.553

10.  Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.

Authors:  Etienne Ruppé; Antoine Andremont
Journal:  Front Microbiol       Date:  2013-05-28       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.